167 related articles for article (PubMed ID: 35421166)
21. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.
Dai Y; Xie CH; Neis JP; Fan CY; Vural E; Spring PM
Head Neck; 2011 Jun; 33(6):786-91. PubMed ID: 21560177
[TBL] [Abstract][Full Text] [Related]
22. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
[TBL] [Abstract][Full Text] [Related]
23. lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5.
Jiang Y; Guo H; Tong T; Xie F; Qin X; Wang X; Chen W; Zhang J
Mol Ther; 2022 Jan; 30(1):448-467. PubMed ID: 34111560
[TBL] [Abstract][Full Text] [Related]
24. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.
Cao W; Yang W; Fan R; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1287-95. PubMed ID: 24068565
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
Xue K; Li J; Nan S; Zhao X; Xu C
Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
27. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
Ma Y; Gong Z; Wang H; Liang Y; Huang X; Yu G
Pathol Res Pract; 2020 Nov; 216(11):153194. PubMed ID: 32916448
[TBL] [Abstract][Full Text] [Related]
28. Effects of ethyl acetate extract of peony (Paeonia suffruticosa) seed coat on the proliferation and apoptosis of oral squamous carcinoma cells through miR-424-3p/STAT3/Survivin pathway.
Ren S; Qing S
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):52-58. PubMed ID: 33040785
[TBL] [Abstract][Full Text] [Related]
29. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
[TBL] [Abstract][Full Text] [Related]
30. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
[TBL] [Abstract][Full Text] [Related]
31. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
32. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
[TBL] [Abstract][Full Text] [Related]
33. IP3R1 dysregulation via mir-200c-3p/SSFA2 axis contributes to taxol resistance in head and neck cancer.
Sanli F; Tatar A; Gundogdu B; Karatas OF
Eur J Pharmacol; 2024 Jun; 973():176592. PubMed ID: 38642666
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer‑associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‑493.
Zhao Z; Xing Y; Liu Y; Jing S
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215214
[TBL] [Abstract][Full Text] [Related]
35. lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
Yang S; Yuan ZJ; Zhu YH; Chen X; Wang W
Head Neck; 2021 Sep; 43(9):2712-2723. PubMed ID: 34033197
[TBL] [Abstract][Full Text] [Related]
36. Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma.
Yang Z; Liao J; Lapidus RG; Fan X; Mehra R; Cullen KJ; Dan H
Cancer Chemother Pharmacol; 2022 Apr; 89(4):469-478. PubMed ID: 35212780
[TBL] [Abstract][Full Text] [Related]
37. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.
Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X
Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.
Chen X; Zhang L; Tang S
Auris Nasus Larynx; 2019 Feb; 46(1):106-113. PubMed ID: 29843929
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
[TBL] [Abstract][Full Text] [Related]
40. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.
Wu Q; Zhao Y; Wang P
Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]